China and India to become drug R&D centers, study finds

Kansas City, USA-based think-tank the Ewing Marion Kauffman Foundation, which specializes in studies of innovation and enterprise, has published a report which predicts that China and India are becoming centers of pharmaceutical R&D. In 2006, the authors of the study found that 5.5% of all drug patent applications worldwide named one inventor or more located in India, with 8.4% naming a person in China. Vivek Wadhwa, of Duke University and Harvard Law School, USA, who led the research, said: "globalization is happening faster than people think." The study, The Globalization of Innovation: Pharmaceuticals, is available at: www.kauffman.org.